Belpointe Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $223K | Sell |
3,099
-190
| -6% | -$14.6K | 0.01% | 972 |
|
|
2025
Q4 | $261K | Sell |
3,289
-130
| -4% | -$10.2K | 0.01% | 863 |
|
|
2025
Q3 | $258K | Sell |
3,419
-662
| -16% | -$45.4K | 0.01% | 841 |
|
|
2025
Q2 | $282K | Sell |
4,081
-3,943
| -49% | -$259K | 0.01% | 769 |
|
|
2025
Q1 | $544K | Sell |
8,024
-1,477
| -16% | -$88.4K | 0.03% | 537 |
|
|
2024
Q4 | $544K | Buy |
9,501
+239
| +3% | +$13.4K | 0.03% | 489 |
|
|
2024
Q3 | $582K | Sell |
9,262
-616
| -6% | -$35.9K | 0.03% | 466 |
|
|
2024
Q2 | $583K | Sell |
9,878
-3,533
| -26% | -$221K | 0.04% | 423 |
|
|
2024
Q1 | $1.07M | Sell |
13,411
-4,323
| -24% | -$330K | 0.08% | 246 |
|
|
2023
Q4 | $1.4M | Buy |
17,734
+3,348
| +23% | +$238K | 0.12% | 164 |
|
|
2023
Q3 | $1M | Sell |
14,386
-350
| -2% | -$24.8K | 0.1% | 193 |
|
|
2023
Q2 | $1.02M | Sell |
14,736
-25,542
| -63% | -$1.82M | 0.11% | 179 |
|
|
2023
Q1 | $2.99M | Buy |
40,278
+3,343
| +9% | +$280K | 0.16% | 124 |
|
|
2022
Q4 | $3.44M | Sell |
36,935
-6,237
| -14% | -$602K | 0.21% | 88 |
|
|
2022
Q3 | $4.12M | Buy |
43,172
+2,465
| +6% | +$244K | 0.28% | 68 |
|
|
2022
Q2 | $3.77M | Sell |
40,707
-1,579
| -4% | -$154K | 0.25% | 79 |
|
|
2022
Q1 | $4.28M | Sell |
42,286
-3,053
| -7% | -$321K | 0.26% | 66 |
|
|
2021
Q4 | $4.68M | Buy |
45,339
+778
| +2% | +$71.9K | 0.29% | 69 |
|
|
2021
Q3 | $3.78M | Buy |
44,561
+12,784
| +40% | +$1.07M | 0.26% | 77 |
|
|
2021
Q2 | $2.65M | Buy |
31,777
+1,230
| +4% | +$101K | 0.19% | 114 |
|
|
2021
Q1 | $2.3M | Buy |
30,547
+1,691
| +6% | +$123K | 0.2% | 106 |
|
|
2020
Q4 | $1.97M | Buy |
28,856
+6,547
| +29% | +$426K | 0.18% | 124 |
|
|
2020
Q3 | $1.3M | Buy |
22,309
+3,016
| +16% | +$188K | 0.15% | 153 |
|
|
2020
Q2 | $1.25M | Buy |
19,293
+1,446
| +8% | +$91.1K | 0.16% | 130 |
|
|
2020
Q1 | $1.06M | Buy |
17,847
+12,319
| +223% | +$822K | 0.19% | 125 |
|
|
2019
Q4 | $411K | Sell |
5,528
-6,487
| -54% | -$455K | 0.05% | 358 |
|
|
2019
Q3 | $758K | Buy |
12,015
+8,515
| +243% | +$505K | 0.12% | 188 |
|
|
2019
Q2 | $191K | Sell |
3,500
-497
| -12% | -$26.8K | 0.04% | 423 |
|
|
2019
Q1 | $215K | Buy |
3,997
+686
| +21% | +$42.3K | 0.04% | 294 |
|
|
2018
Q4 | $217K | Sell |
3,311
-937
| -22% | -$69.9K | 0.06% | 328 |
|
|
2018
Q3 | $334K | Buy |
+4,248
| New | +$304K | 0.05% | 337 |
|
Other funds holding CVS
VCM
VPM
Belpointe Asset Management's CVS Position: Q1 2026 in Review
Belpointe Asset Management reduced its CVS Health (CVS) stake by 5.8% in Q1 2026, selling an estimated $14.6K and leaving 3,099 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #972.
Belpointe Asset Management first reported a position in CVS in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.68M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Belpointe Asset Management held 3,099 shares of CVS Health worth $223K as of Q1 2026.
- Belpointe Asset Management sold 190 CVS Health shares in Q1 2026, an estimated $14.6K.
- CVS Health made up 0.01% of Belpointe Asset Management's portfolio in Q1 2026, its #972 holding.
- Belpointe Asset Management first reported a position in CVS Health in Q3 2018 and has held it in 31 quarters since.
- Belpointe Asset Management's CVS Health position peaked at $4.68M in Q4 2021.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.